Infectious Diseases (except HIV/AIDS)
Showing page 235 of 716 pages of list content
-
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (BBV152) in children from 2 to 18 years of age: an open-label, age-de-escalation phase 2/3 study
This article's authors -
Soluble immune checkpoints are dysregulated in COVID-19 and heavy alcohol users with HIV infection
This article's authors -
Relationship between temperature and relative humidity on the initial spread of COVID-19 cases and deaths in Brazil
This article's authors -
Long-lasting cellular immunity to SARS-CoV-2 following infection or vaccination and implications for booster strategies
This article's authors -
Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic test
This article's authors -
Divergent SARS CoV-2 Omicron-specific T- and B-cell responses in COVID-19 vaccine recipients
This article's authors -
Method versatility in RNA extraction-free PCR detection of SARS-CoV-2 in saliva samples
This article's authors -
SARS-CoV-2 Omicron variant: exploring healthcare workers’ awareness and perception of vaccine effectiveness: a national survey during the first week of WHO variant alert
This article's authors -
Neutralization of ancestral SARS-CoV-2 and variants Alpha, Beta, Gamma, Delta, Zeta and Omicron by mRNA vaccination and infection-derived immunity through homologous and heterologous variants
This article's authors -
Vaccine effectiveness against hospital admission in South African health care workers who received a homologous booster of Ad26.COV2 during an Omicron COVID19 wave: Preliminary Results of the Sisonke 2 Study
This article's authors